3 Result(s)

Article

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

Pembrolizumab-based regimens are conditioned by the expression of PD-L1, but durable response rate is limited by innate and acquired resistance mechanisms. Here, we focus on osteopontin (OPN), an upfront bioma...

Davide Ramoni, Simona Coco, Giovanni Rossi, Chiara Dellepiane, Elisa Bennicelli… in Lung (2024)

Article

CTLA-4 checkpoint blockade in breast cancer, a case in point report

Chiara Dellepiane, Michela Lia… in Journal for ImmunoTherapy of Cancer (2015)

Article

Intradermal influenza vaccination in complete remission cancer patients: molecular insights

Davide Bedognetti, Maria Libera Ascierto… in Journal for ImmunoTherapy of Cancer (2013)